India Panel Favors Favipiravir, Tocilizumab As It Assesses COVID-19 Treatments

Strides Begins Favipiravir Exports, Glenmark to Start Trials

 
• By Vibha Ravi
Coronavirus_Boxing_Glove
India Builds Defenses With Multiple COVID-19 Drug Candidates • Source: Shutterstock

More from COVID-19

More from Scrip